Biopharmaceutical company developing treatments for blood disorders
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Disc Medicine, Inc..
The 1 sources with the most insights about Disc Medicine, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Upcoming top-line data from the Apollo study of bitopertin is a potential catalyst; the speaker had not yet completed a model or formed a clear view.
Upcoming top-line data from the Apollo study of bitopertin is a potential catalyst; the speaker had not yet completed a model or formed a clear view.
Other assets that creators frequently mention in the same content as Disc Medicine, Inc..
The most active sources covering Disc Medicine, Inc. (IRON) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Disc Medicine, Inc. (IRON) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Disc Medicine, Inc. (IRON) most frequently also discuss NBIS, ARWR, SPRB, RGTI, STX. See the "Discussed alongside" section above for full asset pages.